Internal Medicine, Pulmonary Disease · Port Charlotte, FL
NPI
1851528202
Since 2009
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4235 Kings Hwy, Suite 103
Port Charlotte, FL, 33980
Phone (941) 613-1777
Groups this clinician bills Medicare through
Medicare paid, 2024
$416K
5,582 services
Medicare patients, 2024
1,516
Average age 77
Drug cost, 2024
$6.2M
7,957 prescriptions
Company payments, 2025
$8,304
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lohaliz Bobe was code 99214 (office e&m - established), 1,190 times for 680 patients. In total Lohaliz Bobe billed 5,582 services in 41 codes, and Medicare paid $416K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,190 | 680 | $92.97 | $111K |
| 99233 Hospital E&M - Subsequent | Facility | 539 | 258 | $95.91 | $52K |
| 99291 Critical Care E&M | Facility | 505 | 286 | $170.01 | $86K |
| 94727 Pulmonary Function Testing | Office | 488 | 477 | $32.87 | $16K |
| 94729 Pulmonary Function Testing | Office | 488 | 477 | $41.01 | $20K |
| 99213 Office E&M - Established | Office | 313 | 270 | $66.01 | $21K |
| 94010 Pulmonary Function Testing | Office | 310 | 303 | $20.40 | $6,325 |
| 99232 Hospital E&M - Subsequent | Facility | 289 | 193 | $62.68 | $18K |
| 99454 E&M - Miscellaneous | Office | 224 | 77 | $36.43 | $8,160 |
| 94664 E&M - Miscellaneous | Office | 181 | 179 | $13.58 | $2,459 |
| 94060 Pulmonary Function Testing | Office | 179 | 177 | $28.93 | $5,178 |
| 99223 Hospital E&M - Initial | Facility | 166 | 160 | $134.88 | $22K |
| 94762 Pulmonary | Office | 145 | 131 | $18.28 | $2,650 |
| 94618 Pulmonary Function Testing | Office | 94 | 92 | $24.40 | $2,294 |
| 99204 Office E&M - New | Office | 71 | 71 | $115.50 | $8,201 |
By year: 2022 $448K for 6,384 services; 2023 $477K for 6,125 services; 2024 $416K for 5,582 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lohaliz Bobe prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,405 prescriptions and refills. In total Lohaliz Bobe wrote 7,957 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,405 | 2,154 | 312 | $1.4M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 869 | 1,118 | 314 | $26K |
| Prednisone Generic | 653 | 919 | 332 | $3,164 |
| Montelukast Sodium Generic | 449 | 1,214 | 132 | $4,674 |
| Azithromycin Generic | 418 | 736 | 197 | $5,245 |
| Levocetirizine Dihydrochloride Generic | 393 | 984 | 139 | $6,019 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 284 | 428 | 70 | $265K |
| Famotidine Generic | 235 | 613 | 85 | $4,059 |
| Breo Ellipta Fluticasone/Vilanterol | 187 | 287 | 52 | $112K |
| Fluticasone Propionate Generic | 172 | 399 | 75 | $2,545 |
| Methylprednisolone Generic | 159 | 165 | 125 | $1,154 |
| Spiriva Respimat Tiotropium Bromide | 135 | 261 | 44 | $135K |
| Azelastine Hcl Generic | 133 | 258 | 66 | $5,014 |
| Levofloxacin Generic | 123 | 123 | 96 | $455 |
| Prolastin C Alpha-1-Proteinase Inhibitor | 113 | 113 | 11 | $1.1M |
Brand drugs: - claims; generic drugs: 4,294 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lohaliz Bobe $8,304 ($8,304 in general payments such as food, travel and fees) from 26 companies. The largest payer was Genzyme Corporation with $4,789.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 11 | $4,789 |
| AstraZeneca Pharmaceuticals LP AZN | 34 | $752 |
| GlaxoSmithKline, LLC. GSK | 27 | $463 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $309 |
| Insmed, Inc. INSM | 10 | $251 |
| Kerecis Limited | 1 | $234 |
| Actelion Pharmaceuticals US, Inc. JNJ | 14 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $175 |
| Abiomed JNJ | 1 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.